LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
1.020
-0.030 (-2.86%)
At close: Jul 2, 2025, 4:00 PM
1.030
+0.010 (0.98%)
After-hours: Jul 2, 2025, 4:00 PM EDT
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $19.46 million as of July 2, 2025. Its market cap has decreased by -84.80% in one year.
Market Cap
19.46M
Enterprise Value
44.13M
1-Year Change
-84.80%
Ranking
Category
Stock Price
1.02
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $19.46M, a decrease of -91.45%. That is a compound annual growth rate of -46.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 20.03M | -69.65% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |